PTC
RMD icon

Private Trust Company’s ResMed RMD Stock Holding History

Private Trust Company’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$173K Buy
886
+20
+2% +$4.14K 0.01% 869
2026
Q1 		$194K Hold
866
– – 0.02% 792
2025
Q4 		$209K Sell
866
-12
-1% -$3.07K 0.02% 740
2025
Q3 		$240K Sell
878
-5
-0.6% -$1.37K 0.02% 680
2025
Q2 		$228K Sell
883
-62
-7% -$14.8K 0.02% 679
2025
Q1 		$212K Sell
945
-95
-9% -$22.2K 0.02% 687
2024
Q4 		$238K Buy
1,040
+2
+0.2% +$482 0.02% 627
2024
Q3 		$253K Buy
1,038
+124
+14% +$27.7K 0.03% 612
2024
Q2 		$175K Buy
914
+103
+13% +$20.9K 0.02% 702
2024
Q1 		$161K Buy
811
+15
+2% +$2.75K 0.02% 718
2023
Q4 		$137K Sell
796
-16
-2% -$2.46K 0.02% 733
2023
Q3 		$120K Buy
812
+13
+2% +$2.35K 0.02% 738
2023
Q2 		$175K Sell
799
-25
-3% -$5.57K 0.02% 611
2023
Q1 		$180K Sell
824
-3
-0.4% -$651 0.02% 572
2022
Q4 		$172K Buy
827
+5
+0.6% +$1.1K 0.03% 556
2022
Q3 		$179K Hold
822
– – 0.03% 509
2022
Q2 		$172K Sell
822
-7
-0.8% -$1.49K 0.03% 523
2022
Q1 		$201K Sell
829
-30
-3% -$7.26K 0.03% 342
2021
Q4 		$224K Sell
859
-33
-4% -$8.56K 0.03% 361
2021
Q3 		$235K Hold
892
– – 0.03% 373
2021
Q2 		$220K Buy
+892
New +$188K 0.03% 380
2019
Q1 		– Sell
-1,856
Closed -$211K – 364
2018
Q4 		$211K Sell
1,856
-18
-1% -$1.93K 0.05% 326
2018
Q3 		$216K Buy
+1,874
New +$205K 0.04% 350
2014
Q4 		– Sell
-750
Closed -$37K – 995
2014
Q3 		$37K Sell
750
-750
-50% -$38.2K 0.01% 638
2014
Q2 		$76K Buy
+1,500
New +$74.3K 0.02% 458
2013
Q4 		– Sell
-286
Closed -$15K – 1804
2013
Q3 		$15K Hold
286
– – 0.01% 762
2013
Q2 		$13K Buy
+286
New +$13.6K 0.01% 771

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Private Trust Company's RMD Position: Q2 2026 in Review

Private Trust Company increased its ResMed (RMD) stake by 2.3% in Q2 2026, buying an estimated $4.14K and bringing the position to 886 shares worth $173K. The position accounts for 0.01% of the portfolio, ranked #869.

Private Trust Company first reported a position in RMD in Q2 2013 and has held it in 27 quarters since. The position peaked at $253K in Q3 2024. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Private Trust Company held 886 shares of ResMed worth $173K as of Q2 2026.
  • Private Trust Company bought 20 ResMed shares in Q2 2026, an estimated $4.14K.
  • ResMed made up 0.01% of Private Trust Company's portfolio in Q2 2026, its #869 holding.
  • Private Trust Company first reported a position in ResMed in Q2 2013 and has held it in 27 quarters since.
  • Private Trust Company's ResMed position peaked at $253K in Q3 2024.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.